$282.20-9.88 (-3.38%)
VeriSign, Inc., together with its subsidiaries, provides internet infrastructure and domain name registry services that enables internet navigation for various recognized domain names worldwide.
VeriSign, Inc. in the Technology sector is trading at $282.20 with a market capitalization of $25.7B. Wall Street consensus targets $321.40 (5 analysts), implying a +13.9% move over the next 12 months. The stock is currently 10% below its 52-week high of $312.48, remaining 8.4% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $434.60M↑ | $428.90M↑ | $425.30M↑ | $419.10M↑ | $409.90M |
| Gross Profit | $384.60M↑ | $379.70M↑ | $376.30M↑ | $370.30M↑ | $360.80M |
| Operating Income | $296.30M↑ | $293.60M↑ | $284.80M↑ | $284.30M↑ | $280.70M |
| Net Income | $216.50M↑ | $214.50M↑ | $206.20M↓ | $212.80M↑ | $207.40M |
VeriSign, Inc., together with its subsidiaries, provides internet infrastructure and domain name registry services that enables internet navigation for various recognized domain names worldwide. The company provides root zone maintainer services, ope...
VeriSign (VRSN) has the potential for above-average growth with multiple catalysts for the domain re

While VeriSign has trailed the broader market over the past 52 weeks, Wall Street remains moderately optimistic about the stock’s outlook.

Verisign's structural edge and recurring revenue stand out, while Donnelley Financial's software shift offers growth potential amid industry uncertainty.

Internet Software & Services benefits from digitalization and AI, though disruption and competition temper the outlook. Buy VRSN.

Bidzos retains 409,639 shares valued at $122.56 million, signaling continued confidence in the internet infrastructure provider.
Academic risk and quality models computed from VRSN's own filings and price history, not from analyst opinion.
Strong on 8 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M above -1.78, the threshold where the model flags an elevated likelihood of earnings manipulation.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 23.6% reading.
Fama-French 5-factor market beta. The five factors explain 7% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.